# Supplemental NDA (sNDA)

> An application to change an already approved drug's NDA, most often to add a new indication, patient population, dose or formulation.

Source: https://www.quantisnow.com/glossary/snda
Topic: Glossary / Biotech and FDA
Also known as: sNDA, supplemental new drug application, label expansion, efficacy supplement
Last updated: 2026-10-27

A supplemental New Drug Application (sNDA) is a request to the FDA to change the terms of an already approved [NDA](https://www.quantisnow.com/glossary/nda). The most market-relevant type is the efficacy supplement, used to add a new indication or expand the approved patient population. The equivalent for biologics is a supplemental BLA (sBLA).

## How it works

Supplements cover many kinds of changes: new indications, new dosing regimens, new formulations or strengths, labeling updates and manufacturing changes. Efficacy supplements typically require new clinical data, often a [Phase 3](https://www.quantisnow.com/glossary/phase-3-trial) trial in the new population.

Under PDUFA, efficacy supplements have review goals of 10 months for standard review and 6 months for [priority review](https://www.quantisnow.com/glossary/priority-review), measured from receipt. As with an original application, the result is an approval or a [complete response letter](https://www.quantisnow.com/glossary/complete-response-letter). Many routine manufacturing and labeling supplements are minor and never make news.

## Why it matters for traders

For commercial-stage drugmakers, label expansions are how a drug's sales keep growing after launch. An sNDA approval for a large new indication, such as moving a cancer drug into an earlier line of therapy, can materially lift revenue forecasts. Things traders watch:

- **Size of the new population** relative to the current label.
- **The PDUFA date** for the supplement, disclosed by the company.
- **Label wording.** A narrower-than-expected indication can disappoint even on approval.

## Example

Northwind Therapeutics (NWTX) markets a drug approved for adults with a rare liver disease, a market of about 20,000 US patients. It files an sNDA to add a second, related condition affecting about 30,000 patients, with standard review. If approved, the addressable population rises 150% to roughly 50,000.

## FAQ

### What is the difference between an NDA and an sNDA?

An NDA seeks the first approval of a drug. An sNDA seeks to change an existing approval, for example to add a new use.

### Does an sNDA need new trials?

Efficacy supplements for new indications usually do. Manufacturing or labeling supplements often do not.

## Related terms

- [New Drug Application (NDA)](https://www.quantisnow.com/glossary/nda.md): The formal application a drugmaker submits to the FDA requesting approval to market a new small-molecule drug in the United States.
- [Biologics License Application (BLA)](https://www.quantisnow.com/glossary/bla.md): The application a company submits to the FDA to market a biologic, such as an antibody, vaccine or gene therapy, in the United States.
- [PDUFA date](https://www.quantisnow.com/glossary/pdufa-date.md): The target date by which the FDA aims to approve or reject a new drug or biologic application under the Prescription Drug User Fee Act.
- [Priority review](https://www.quantisnow.com/glossary/priority-review.md): An FDA designation that shortens the review goal for a drug application to 6 months instead of the standard 10 months.
- [Phase 3 clinical trial](https://www.quantisnow.com/glossary/phase-3-trial.md): The large, late-stage trial that tests whether a drug works and is safe in a broad patient population, usually forming the basis for an FDA application.
- [Complete response letter (CRL)](https://www.quantisnow.com/glossary/complete-response-letter.md): A letter from the FDA stating it cannot approve a drug or biologic application in its current form and explaining the deficiencies to fix.

## On Quantisnow

- [FDA approval process](https://www.quantisnow.com/guides/fda-approval-process)
- [Live feed: FDA Approvals](https://www.quantisnow.com/news/fda)
- [Latest FDA approvals and announcements](https://www.quantisnow.com/top/fda-approvals)
